tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Charlotte’s Web Tapped for Landmark Medicare and Medicaid CBD Pilot for Senior Cancer Patients

Story Highlights
  • Charlotte’s Web will supply reimbursable, science-backed CBD products to senior cancer patients under a new Medicare and Medicaid pilot program.
  • The initiative expands Charlotte’s Web’s medical-channel reach with a secure portal, advisory-led oversight, and nonprofit support to deliver affordable, evidence-based CBD care for seniors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Charlotte’s Web Tapped for Landmark Medicare and Medicaid CBD Pilot for Senior Cancer Patients

Claim 50% Off TipRanks Premium and Invest with Confidence

Charlotte’s Web Holdings ( (TSE:CWEB) ) has provided an update.

Charlotte’s Web has been selected as a premier CBD provider for a landmark pilot program run by the Center for Medicare and Medicaid Innovation that, for the first time, will reimburse science-backed CBD products for senior cancer patients under Medicare and Medicaid. Beginning in early 2026, the company will supply tailored CBD products via a secure online healthcare portal as part of its expanding medical channel, aiming to improve accessibility and affordability for oncology patients, particularly lower-income seniors, while potentially reducing downstream healthcare costs. The program is underpinned by Charlotte’s Web’s Scientific Advisory Board, which will guide product integrity, education and innovation, and by nonprofit partner Realm of Caring, which will deliver evidence-based counseling, dosing guidance and outcomes tracking, creating a patient-centered, data-rich model for integrating CBD into mainstream senior supportive care.

The most recent analyst rating on (TSE:CWEB) stock is a Hold with a C$0.13 price target. To see the full list of analyst forecasts on Charlotte’s Web Holdings stock, see the TSE:CWEB Stock Forecast page.

Spark’s Take on TSE:CWEB Stock

According to Spark, TipRanks’ AI Analyst, TSE:CWEB is a Neutral.

The overall stock score is primarily influenced by significant financial challenges, including declining revenues and increased financial risk due to higher leverage. Technical indicators suggest a bearish trend with weak momentum, while valuation metrics highlight ongoing losses and lack of profitability. The absence of earnings call and corporate events data limits additional insights.

To see Spark’s full report on TSE:CWEB stock, click here.

More about Charlotte’s Web Holdings

Charlotte’s Web Holdings is a Colorado-based pioneer and market leader in hemp-derived CBD wellness products, supplying non-intoxicating, science-backed CBD formulations through retail, healthcare, and direct-to-consumer channels. The company focuses on quality, consistency and clinical validation, targeting wellness applications such as pain, anxiety, sleep and other age-related conditions, and works closely with medical practitioners and scientific advisors to advance evidence-based cannabinoid therapies.

Average Trading Volume: 157,060

Technical Sentiment Signal: Buy

Current Market Cap: C$33.48M

See more insights into CWEB stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1